Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. (Q34740245)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. |
scientific article |
Statements
1 reference
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. (English)
1 reference
David M Brown
1 reference
Quan Dong Nguyen
1 reference
Dennis M Marcus
1 reference
David S Boyer
1 reference
Sunil Patel
1 reference
Leonard Feiner
1 reference
Patricio G Schlottmann
1 reference
Amy Chen Rundle
1 reference
Jiameng Zhang
1 reference
Roman G Rubio
1 reference
Anthony P Adamis
1 reference
Jason S Ehrlich
1 reference
J Jill Hopkins
1 reference
RIDE and RISE Research Group
1 reference
1 reference
Identifiers
1 reference